NCT04116632View on ClinicalTrials.gov

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions
Obese But Otherwise Healthy Participants
Interventions
DRUG

BMS-963272

Single dose with varying frequency among groups

DRUG

Placebo

Specified dose on specified days

Trial Locations (1)

66219

PRA Health Sciences - Lenexa, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY